Literature DB >> 19192999

Management of smoking cessation in patients with psychiatric disorders.

Karl Fagerström1, Henri-Jean Aubin.   

Abstract

BACKGROUND: There is a close relationship between tobacco smoking and psychiatric disorders, and a higher proportion of individuals with mental health conditions smoke compared with the general population. Due to the increased smoking prevalence in this population, patients with psychiatric conditions are at greater risk of smoking-related morbidity and mortality and experience detrimental effects on their quality of life. However, while the majority of individuals with a history of mental health conditions appreciate that smoking is detrimental to their health, they are less likely to quit smoking and have a lower success rate during quit attempts compared with the general population. SCOPE: Peer-reviewed articles were identified from PubMed using the inclusive date-range of 1990 - October 2008 and the search terms; depression, mental health, psychiatric disorders, schizophrenia, and smoking cessation. Articles were selected from the search results to provide a general overview of some of the main issues for smokers with psychiatric disorders in general and specifically, those with schizophrenia and depression. The evidence from smoking cessation trials within these populations was also reviewed.
FINDINGS: Nicotine has some positive effects on symptoms of psychiatric disorders and it has been proposed that patients with mental health conditions may smoke as a form of self-medication. Further, several studies have shown that some symptoms of psychiatric disorders may be exacerbated by nicotine withdrawal. Therefore, attempts to quit smoking pose additional problems to patients with mental health problems.
CONCLUSION: Traditional programmes for smoking cessation may not always be suitable for psychiatric patients due to their neuropsychological profile. Preliminary evidence suggests that more flexible, open-ended, combination approaches of pharmacotherapy and counselling may be more successful. In addition, identification and treatment of nicotine addiction remains very low in patients with mental health conditions and far more needs to be done to raise the awareness and ability of psychiatrists to diagnose and treat patients with nicotine problems.

Entities:  

Mesh:

Year:  2009        PMID: 19192999     DOI: 10.1185/03007990802707568

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  26 in total

1.  Pilot Implementation of a Wellness and Tobacco Cessation Curriculum in North Carolina Group Homes.

Authors:  Hannah M Baker; Leah M Ranney; Adam O Goldstein
Journal:  Community Ment Health J       Date:  2015-12-28

2.  Perception of smoking risks and motivation to quit among nontreatment-seeking smokers with and without schizophrenia.

Authors:  Deanna L Kelly; Heather G Raley; Suzanne Lo; Katherine Wright; Fang Liu; Robert P McMahon; Eric T Moolchan; Stephanie Feldman; Charles M Richardson; Heidi J Wehring; Stephen J Heishman
Journal:  Schizophr Bull       Date:  2010-11-01       Impact factor: 9.306

3.  Predictors of smoking severity in patients with schizophrenia and alcohol use disorders.

Authors:  Zsuzsa Szombathyne Meszaros; Jacqueline A Dimmock; Robert J Ploutz-Snyder; Ynesse Abdul-Malak; Luba Leontieva; Kelly Canfield; Steven L Batki
Journal:  Am J Addict       Date:  2011-07-18

Review 4.  Smoking in schizophrenic patients: A critique of the self-medication hypothesis.

Authors:  Francesca Manzella; Susan E Maloney; George T Taylor
Journal:  World J Psychiatry       Date:  2015-03-22

5.  Smoking cessation after brain damage does not lead to increased depression: implications for understanding the psychiatric complications of varenicline.

Authors:  Daniel Tranel; Ashton McNutt; Antoine Bechara
Journal:  Cogn Behav Neurol       Date:  2012-03       Impact factor: 1.600

6.  Socio-economic disadvantage at the area level poses few direct barriers to smoking cessation for Australian smokers: findings from the International Tobacco Control Australian cohort survey.

Authors:  Timea R Partos; Ron Borland; Mohammad Siahpush
Journal:  Drug Alcohol Rev       Date:  2012-03-04

7.  Smoking outcome by psychiatric history after behavioral and varenicline treatment.

Authors:  Jennifer B McClure; Gary E Swan; Sheryl L Catz; Lisa Jack; Harold Javitz; Tim McAfee; Mona Deprey; Julie Richards; Susan M Zbikowski
Journal:  J Subst Abuse Treat       Date:  2010-04-02

8.  The relationship between reward-based learning and nicotine dependence in smokers with schizophrenia.

Authors:  Christopher G Ahnallen; Gabrielle I Liverant; Kristin L Gregor; Barbara W Kamholz; James J Levitt; Suzy Bird Gulliver; Diego A Pizzagalli; Vamsi K Koneru; Gary B Kaplan
Journal:  Psychiatry Res       Date:  2012-02-17       Impact factor: 3.222

Review 9.  Anxiety and Depression in Bidirectional Relations Between Pain and Smoking: Implications for Smoking Cessation.

Authors:  Emily L Zale; Stephen A Maisto; Joseph W Ditre
Journal:  Behav Modif       Date:  2015-10-14

Review 10.  Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.

Authors:  Henri-Jean Aubin; Amandine Luquiens; Ivan Berlin
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.